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It has previously been reported that patients with an
implantable cardioverter-deﬁbrillator (ICD) may have a
slightly higher deﬁbrillation threshold (DFT) in an upright
position compared to a supine position.1 However, the
signiﬁcance of this and the potential impact on clinical
practice remains unclear. We report a case of deﬁbrillation
failure caused by an increase in DFT in the upright position,
leading to prolonged, near-fatal cardiac arrest in a patient
who had previous ICD implantation including successful
DFT testing in a supine position. ICD system revision with
addition of an azygos vein coil successfully corrected this
condition, as demonstrated by orthostatic DFT testing.
Case report
The patient is a 47-year-old man with a prior history of
nonischemic, dilated cardiomyopathy and ejection fraction
15%–20%. He underwent initial implantation of a single-
chamber, single-coil ICD (Protecta VR D334VRG; Med-
tronic, Minneapolis, MN) for primary prevention in October
2012. The patient’s past medical history is also signiﬁcant for
morbid obesity, hypertension, type II diabetes, and renal
insufﬁciency. Because of the patient’s body habitus, non-
ischemic cardiomyopathy, and young age, DFT testing was
performed at the time of implant. After induction of
ventricular ﬁbrillation (VF) by T wave shock, a 15 J shock
failed but a follow-up 25 J shock from the ICD successfully
restored sinus rhythm. The patient’s device has a 35 J
maximal output with a 10 J safety margin maintained. After
the uneventful ICD implantation, he remained stable until
recently, when he developed an episode of VF during sleep,KEYWORDS Deﬁbrillation threshold; Orthostatic; Ventricular ﬁbrillation;
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ICD. An evaluation including stress echocardiography was
negative for ischemia. No additional coronary angiogram
was performed owing to baseline renal insufﬁciency and
because he already had two previous coronary angiograms
within the last 5 years that showed no signiﬁcant obstructive
coronary artery disease. Conservative medical management
was therefore recommended and the patient’s heart failure
management was intensiﬁed with close follow-up by his
cardiologist.
Five months after the initial VF event and despite an
apparent stable heart failure status, the patient developed
sudden syncope without prodrome while sitting in a chair at
home and was later found to be in cardiac arrest. According
to the family, the patient was able to maintain an upright
position in the chair. Subsequent ICD interrogation showed
VF that was appropriately detected and six consecutive,
maximal-energy shocks at 35 J (including a reversed polarity
with the last shock) were delivered but failed to terminate the
VF (Figure 1A–C). After exhaustion of device therapy, the
patient remained in VF for approximately 6–7 minutes until
paramedics arrived with an automated external deﬁbrillator.
The patient was immediately placed in the supine position
and a single shock from the automated external deﬁbrillator
successfully converted the patient back into sinus rhythm
(Figure 1D). After the patient was placed in the supine
position, he subsequently developed 3 more VF episodes in
the ﬁeld, all of which were successfully detected and treated
by the ICD (Figure 1E and F). The patient was initially
transferred to a nearby hospital but was subsequently trans-
ferred to Borgess Medical Center for deﬁnitive management.
Two days after the initial event, the patient did develop
another episode of VF while supine in the hospital, which
was again successfully detected and treated by the ICD with
a 35 J shock. Following successful resuscitation including a
cooling protocol, he was able to make a complete recovery
with minimal residual neurologic deﬁcit. Of note, chestpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 A clinically signiﬁcant increase in deﬁbrillation
threshold (DFT) may occur in the upright body
position, especially in patients with severe obesity.
 Implantation of an azygos vein coil may
substantially reduce DFT.
 Orthostatic DFT testing may help identify and
reduce the chance of failure to deﬁbrillate in high-
risk patients.
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demonstrated an orthostatic shift in the ICD can position
relative to the heart, but no signiﬁcant change in the lead
position was found as compared to the one at initial implant
(Figure 2A–D).
Because of the apparent dependence of successful deﬁb-
rillation on body position and the relatively high DFT during
the initial implant, we elected to revise the patient’s ICD
system with addition of an azygos vein coil and subsequently
performed DFT testing in a supine as well as in an upright
position.
The patient was taken to the electrophysiology lab, where
the left precordium was prepared and draped in the usual
fashion. The axillary vein was accessed and the azygos vein
was engaged using a 6 F Judkins-right-4 (JR4) diagnostic
coronary catheter, as described by Cooper et al,2 and a Storq
wire (Johnson & Johnson Medical, NV, Diegem, Belgium).
A 9 F long sheath was advanced over the JR4 and Storq wire,
passing the initial torturous portion of the azygos vein. This
allowed successful implantation of an azygos coil posterior
to the heart (Figure 2E and F). At the end of the procedure,
VF was induced and a 15 J shock from the device was able to
successfully deﬁbrillate the patient (not shown). The patient
underwent further DFT testing the next morning in an
upright position. The head of the bed was propped up about
70–80 degrees until the patient was in an upright posture
similar to the one that he was in during the initial prolonged
cardiac arrest. VF was again induced by T wave shock.
Following successful detection of VF, an initial 25 J shock
was purposefully delivered using the previous right ventric-
ular (RV) coil–to–ICD can conﬁguration to conﬁrm that the
failure to deﬁbrillate was due to an increase in DFT in the
upright position (Figure 3A). This indeed failed to terminate
the VF. Immediately after that, with the patient still in VF in
an upright position, a second 15 J manual shock using the
new conﬁguration (B4AX, RV coil to azygos coil/ICD can)
incorporating the azygos coil was delivered within 10
seconds and successfully deﬁbrillated the patient
(Figure 3B). The patient tolerated the procedure well and
was discharged home on amiodarone to suppress ventricular
arrhythmias that may trigger further VF. At his post hospital
follow-up one month after the event, the patient had
completely recovered, with no residual neurologic deﬁcit
or recurrent VF episodes.Discussion
This case illustrates the potential critical impact of orthostatic
increase in DFT on survival in certain clinical situations, and
it is thought-provoking that orthostatic DFT testing is yet to
become part of our routine electrophysiology practice even
in patients at high risk for VF. It also demonstrates that
modiﬁcation of the shock vector utilizing an azygos coil can
substantially reduce the DFT in both supine and upright
positions.
Inﬂuence of body position on DFT has long been studied
by Schauerte et al,1 who found a signiﬁcant increase in DFT
in an upright position compared to the supine position.
However, the mean magnitude of this increase is relatively
small, about 1.9–2.0 J, which would not be expected to cause
complete failure to deﬁbrillate in the patient presented here,
since a 10 J safety margin was observed during the initial
implant.1,3 Our patient’s relatively increased DFT at baseline
and subsequent treatment with amiodarone in the hospital
may have contributed to the failure to deﬁbrillate. However,
the main factor in this case appears to be the orthostatic
increase in DFT when the patient was in an upright position.
This is supported by the three consecutive, successful shocks
from the device when the patient was placed in a supine
position shortly after he had already failed 6 maximal-energy
shocks in a sitting position and after greater than 7 minutes of
continuous VF. Presence of VF as short as 10 seconds has
been shown to increase DFT signiﬁcantly, and prolonged
cardiac arrest due to VF was reported to markedly increase
the energy requirement for successful deﬁbrillation.4,5 All
ﬁve spontaneous VF episodes (one before the recent cardiac
arrest and four afterward) occurring when the patient was
supine were successfully deﬁbrillated by the ICD. Additional
evidence supporting an orthostatic increase in DFT came
from failure to deﬁbrillate at 25 J during repeat DFT testing
in an upright position using the original conﬁguration when
the DFT was estimated at 25 J or less at initial implant in a
supine position, although the patient’s true DFT may have
gradually increased over the years.6,7 We did not observe any
other clear etiology (such as signiﬁcant change in the lead
position on x-ray or worsening heart failure and ejection
fraction) to explain the increased DFT, other than the change
in body position.
The mechanism underlying the increased DFT in the
upright position remains speculative.1 The inferior and
anterior displacement of the ICD can relative to the intra-
venous lead system after the patient assumes an upright
position, especially in patients who have severe obesity such
as the one presented here, may have contributed to the
increased DFT. As shown in Figure 2, owing to the anterior
shift in the can position, the shock vector between the can
and RV coil may encompass less of the cardiac mass in the
upright position compared to the supine one, thereby
potentially increasing the DFT. Additionally, hemodynamic
changes and increased sympathetic tone in an upright
position may also inﬂuence the DFT.1,8 Having a dual
venous coil system, especially with addition of an azygos
Figure 1 Detection and treatment of ventricular ﬁbrillation (VF) in both the upright and supine positions.A: Initial detection of VF when patient was sitting up
in a chair. B, C: Six consecutive shocks from the implantable cardioverter-deﬁbrillator (ICD) failed to deﬁbrillate. Only shocks 1 (B) and 6 (C) are shown.
D: Successful deﬁbrillation by an automated external deﬁbrillator (AED) after patient was placed in a supine position. E, F: Patient developed 3 additional VF
episodes in the ﬁeld after being placed in the supine position. All these were successfully treated by the ICD. Only episodes 1 (E) and 3 (F) are shown. Arrows
indicate the time when shock was delivered by the ICD.
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mitigate these position-related changes. In our own experi-
ence of six patients including this one, addition of an azygos
shocking coil was successful in all and led to substan-
tially reduced DFT in most cases (unpublished personalobservation). There are other potential alternatives to reduce
the DFT and increase the safety margin, such as addition of a
superior vena cava coil or subcutaneous array, switching to a
higher-energy device with 41 J output, or utilizing alternative
devices that allow adjustable tilt.9,10 However, a superior
Figure 2 Posterior-anterior (PA) and lateral views of the implantable cardioverter-deﬁbrillator (ICD) system in both supine and upright positions. A, B: Chest
x-ray in the supine position. C, D: Patient’s ICD can was seen to be inferiorly (C) and anteriorly displaced (D) in the upright position compared to the supine one
(A, B). In the upright position, the shock vector between the right ventricular coil and can (their midpoints connected with dashed lines) appears to encompass
less of the cardiac mass, especially the left ventricle (D). E, F: PA (E) and lateral (F) views in the upright position after addition of an azygos vein coil (arrow).
The shock vector between the coils and can now encompasses more of the left ventricle in the upright position (F).
Heart Rhythm Case Reports, Vol 2, No 4, July 2016316vena cava coil may not lead to as much reduction as the
azygos coil,11 and the subcutaneous array or other methods
may not adequately address the issue of orthostatic changes
and may not offer enough safety margin for this high-risk
patient.
To our knowledge, this is the ﬁrst report of upright body
posture being a critical factor for failed deﬁbrillation in an
out-of-hospital cardiac arrest. It has been long observed thata signiﬁcant percentage of patients with deﬁbrillators and
high DFTs die of sudden cardiac death apparently owing to
inadequate deﬁbrillation energy or inadequate sensing, but
orthostatic increase in the DFT may have also played a role,
as presented in this dramatic case.12 If this patient had not
been successfully resuscitated, the failure to deﬁbrillate here
would have been simply attributed to high DFT alone. It is
probably uncommon for patients to develop VF and still be
Figure 3 Deﬁbrillation threshold testing when patient was in a sitting position with and without the azygos coil in the shock circuit. A: Using the initial right
ventricular (RV) coil–to–ICD can conﬁguration, a 25 J shock failed to deﬁbrillate the patient. B: Immediately following the failure using the old conﬁguration, a
15 J manual shock using the new RV coil–to–azygos vein/ICD can conﬁguration successfully converted the patient to a paced rhythm.
317Liu et al Failure to Deﬁbrillate in Upright Positionable to maintain an upright position; however, failure to
deﬁbrillate early can lead to prolonged VF and may increase
the chance of subsequent deﬁbrillation failure even if
patients eventually collapse and assume the supine position.
Conclusion
In patients who have risk factors for high DFT, such as
severe obesity; advanced, dilated cardiomyopathy; and
multiple comorbidities, orthostatic change can cause addi-
tional, clinically signiﬁcant increase in DFT and may lead to
potential sudden cardiac death owing to failure to deﬁbril-
late. This situation may be overlooked by the currently used
DFT testing protocols, which test patients in a supine
position. Orthostatic DFT testing in such patients may help
predict future deﬁbrillation failures and, if necessary, ICD
system revision with addition of an azygos vein coil may
help correct an excessive orthostatic increase in DFT.
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